Green Thumb Industries (GTBIF) Change in Receivables (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Change in Receivables came in at $628000.0 in Q1 2026, up 111.69% YoY from $296659.9 in Q1 2025, and up 636.75% on a QoQ basis from -$117000.0 in Q4 2025.
Green Thumb Industries (GTBIF) Change in Receivables (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Change in Receivables data on file, last reported at $628000.0 in Q1 2026.
- Quarterly Change in Receivables rose 111.69% year-over-year to $628000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 million (up 203.92% YoY) and the FY2025 annual result came in at -$1.1 million, down 111.09% from the prior year.
- Change in Receivables rose to $628000.0 in Q1 2026, from -$117000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $9.2 million in Q1 2024 to a low of -$5.4 million in Q1 2025.
- A 5-year average of $1.8 million and a median of $150000.0 in 2022 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2024 — Change in Receivables surged 76616.67% — and 2025, when it sank 158.35%.
- Tracing GTBIF's Change in Receivables over 5 years: stood at $150000.0 in 2022, then soared by 2784.67% to $4.3 million in 2023, then decreased by 10.58% to $3.9 million in 2024, then plunged by 103.02% to -$117000.0 in 2025, then soared by 636.75% to $628000.0 in 2026.
- The last three Change in Receivables figures came in at $628000.0 (Q1 2026), -$117000.0 (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.80 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.56 Bn | 22.76 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.21 Bn | 19.55 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.46 Bn | 15.07 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Green Thumb Industries | 1.66 Bn | 1.38 Bn | 137.87 Mn | 1.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.19 Mn |
| Jun 30, 2026 | 1.19 Mn |
| Mar 31, 2026 | 628,000.00 |
| Mar 31, 2026 | 628,000.00 |
| Dec 31, 2025 | -117,000.00 |
| Dec 31, 2025 | -117,000.00 |
| Sep 30, 2025 | 4.94 Mn |
| Sep 30, 2025 | 4.94 Mn |
| Jun 30, 2025 | -545,000.00 |
| Jun 30, 2025 | -545,000.00 |
| Mar 31, 2025 | -5.37 Mn |
| Mar 31, 2025 | -5.37 Mn |
| Dec 31, 2024 | 3.87 Mn |
| Dec 31, 2024 | 3.87 Mn |
| Sep 30, 2024 | -372,000.00 |
| Sep 30, 2024 | -372,000.00 |
| Jun 30, 2024 | -2.85 Mn |
| Jun 30, 2024 | -2.85 Mn |
| Mar 31, 2024 | 9.21 Mn |
| Mar 31, 2024 | 9.21 Mn |